drugset / Trial / NCT00838708
Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated Pruritus
RandomizedCrossoverQuadruple-blindTreatment
Summary
Pruritus is an essential feature for the diagnosis of atopic dermatitis and may play an important part in disease progression. Itching has a significant impact on the quality of life of AD sufferers, in particular night-time itching leading to sleep disturbance and subsequent poor daytime performance. The objective of this study is to determine whether SRD174 Cream is a safe and effective therapy for moderate to severe pruritus associated with atopic dermatitis.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-07
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nalmefene | Small molecule | — | Topical |